Appetite suppressant drugs as inhibitors of human cytochromes P450:: In vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine

被引:13
作者
von Moltke, LL
Greenblatt, DJ
Ciraulo, DA
Grassi, JM
Granda, BW
Duan, SX
Harmatz, JS
Shader, RI
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] New England Med Ctr, Div Clin Pharmacol, Boston, MA 02111 USA
[3] Boston Univ, Sch Med, Dept Psychiat, Boston Med Ctr, Boston, MA 02215 USA
[4] Vet Affairs Med Ctr, Boston, MA USA
关键词
D O I
10.1097/00004714-199808000-00015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The activity of D-fenfluramine, L-fenfluramine, and phentermine as inhibitors of five human cytochromes P450 was evaluated using human Liver microsomes in vitro. AU three compounds produced negligible inhibition of P450-1A2, -2C9, -2E1, and -3A. Phentermine also did not inhibit P450-2D6. However, D- and L-fenfluramine significantly inhibited P450-2D6 activity as measured by dextromethorphan O-demethylation, with mean 50% inhibitory concentrations (15.1 mu M) within one order of magnitude of that for fluoxetine (2.7 mu M). Findings from the in vitro assay are consistent with clinical studies showing significant inhibition of desipramine clearance by coadministration of fenfluramine.
引用
收藏
页码:338 / 341
页数:4
相关论文
共 26 条
  • [1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    Abenhaim, L
    Moride, Y
    Brenot, F
    Rich, S
    Benichou, J
    Kurz, X
    Higenbottam, T
    Oakley, C
    Wouters, E
    Aubier, M
    Simonneau, G
    Begaud, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) : 609 - 616
  • [2] Dexfenfluramine hydrochloride: An anorexigenic agent
    Bever, KA
    Perry, PJ
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (18) : 2059 - 2072
  • [3] Valvular heart disease associated with fenfluramine-phentermine
    Connolly, HM
    Crary, JL
    McGoon, MD
    Hensrud, DD
    Edwards, BS
    Edwards, WD
    Schaff, HV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) : 581 - 588
  • [4] Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO
  • [5] 2-0
  • [6] Drug therapy for obesity in the elderly
    Dvorak, R
    Starling, RD
    CallesEscandon, J
    Sims, EAH
    Poehlman, ET
    [J]. DRUGS & AGING, 1997, 11 (05) : 338 - 351
  • [7] FOGELSON DL, 1997, M J PSYCHIAT, V154, P436
  • [8] GREENBLATT DJ, 1997, DRUG DRUG INTERACTIO
  • [9] Cytochrome p450 enzymes: Interpretation of their interactions with selective serotonin reuptake inhibitors .1.
    Harvey, AT
    Preskorn, SH
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (04) : 273 - 285
  • [10] HO JW, 1992, LIFE SCI, V52, P21